Harrow Health, Inc. 8.625% Senior Notes due 2026
USD25.61
+0.05 (+0.19%)
CEO
Mark L. Baum
IPO Date
2021-05-07
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
NASDAQ
Country
US
Open
$25.56
Prev. Close
$25.56
Day Low
$25.53
Day High
$25.63
52W Low
$25.00
52W High
$25.72
Market Cap
$1.37B
Volume
0.01M
| 7,500 |
| $8.11 |
| 14 Nov 2023 | SAHAREK JOHN P. | Chief Commercial Officer | M-Exempt | Acquired | 20,000 | $0.00 |
| 14 Nov 2023 | SAHAREK JOHN P. | Chief Commercial Officer | F-InKind | Disposed | 9,778 | $12.83 |
| 14 Nov 2023 | SAHAREK JOHN P. | Chief Commercial Officer | M-Exempt | Disposed | 20,000 | $4.16 |
| 20 Sept 2023 | Opaleye Management Inc. | 10 percent owner | P-Purchase | Acquired | 5,983 | $14.49 |
| 20 Sept 2023 | Opaleye Management Inc. | 10 percent owner | P-Purchase | Acquired | 14,017 | $14.65 |
| 15 Aug 2023 | BAUM MARK L | director, officer: Chief Executive Officer | P-Purchase | Acquired | 5,800 | $17.05 |
| 20 Jul 2023 | SAHAREK JOHN P. | Chief Commercial Officer | M-Exempt | Acquired | 277,200 | $0.00 |
| 20 Jul 2023 | SAHAREK JOHN P. | Chief Commercial Officer | F-InKind | Disposed | 109,080 | $18.23 |